Is a complete VNRX research report available?

No complete published report is available for VolitionRx Limited (VNRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

VolitionRx Limited (VNRX)

NYSEAMERICAN: VNRX · USD

$1.00

-0.08 (-7.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VNRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.3M
Revenue (ttm)	2.5M
Net income (ttm)	-24.6M
EPS (ttm)	-$4.20
Shares out	8.3M
Volume	176,835
Beta	1.12
Price target	$17.0	+1597.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5M
Net income (ttm): -24.6M
EPS (ttm): -$4.20
Market cap: 8.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VNRX indicators

Market & fundamental data

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000093314
Company name	VolitionRx Limited
Country	United States
Country code	US
Cusip	928661206
Employees	67
Employees Change	-8%
Employees Change Percent	-10.67
Enterprise value	$16.9M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.9
Industry PE Fwd	18.91
Isin	US9286612067
Last refreshed	2026-07-26
Market cap	$8.3M
Market cap category	Nano-Cap
Price	$1
Price currency	USD
Rev Per Employee	36,807.09x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2835
Symbol	VNRX
Website	https://volition.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-295.29%
EV Sales Forward	7.03x
EV/Sales	6.87x
FCF yield	-249.24%
P/S ratio	3.38x
PS Forward	3.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,258.47%
EBITDA Margin	-1,201.52%
Gross margin	100%
Gross Profit	$2.5M
Gross Profit Growth	88.49%
Gross Profit Growth Q	299.81%
Gross Profit Growth3 Y	93.2%
Gross Profit Growth5 Y	129.88%
Net Income	$-24.6M
Net Income Growth Years	2%
Pretax Margin	-1,002.82%
Profit Per Employee	$-367,135
ROA	-153.5
Roa5y	-101.4
ROCE	479.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-34.13%
Cagr1y	-93.21%
Cagr3y	-67.95%
Cagr5y	-56.09%
EPS Growth Quarters	11
EPS Growth Years	3
Revenue Growth	88.49x
Revenue Growth Q	299.81x
Revenue Growth Quarters	5x
Revenue Growth Years	5x
Revenue Growth3 Y	93.2x
Revenue Growth5 Y	129.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.28
Assets	$9M
Cash	$3.1M
Current Assets	$4.5M
Current Liabilities	$13.6M
Debt	$11.7M
Equity	$-33.4M
Interest Coverage	-7.32
Liabilities	$42.4M
Long Term Assets	$4.5M
Long Term Liabilities	$28.8M
Net Cash	$-8.6M
Net Cash By Market Cap	$-103
Tangible Book Value	$-32.3M
Tangible Book Value Per Share	$-4.07
WACC	16.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.33
Net Working Capital	$-7.6M
Quick ratio	0.25
Working Capital	$-9.1M
Working Capital Turnover	$-0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.87%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.46%
1Y total return	-93.2%
200-day SMA	4.49
3Y total return	-96.71%
50-day SMA	1.69
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.37%
All Time High	185.6
All Time High Change	-99.46%
All Time High Date	2014-09-22
All Time Low	0.99
All Time Low Change	1.01%
All Time Low Date	2026-07-24
ATR	0.13
Beta	1.12
Beta1y	2.59
Beta2y	0.65
Ch YTD	-80.44
High	1.1
High52	16
High52 Date	2025-07-28
High52ch	-93.75%
Low	0.99
Low52	0.99
Low52 Date	2026-07-24
Low52ch	1.01%
Ma50ch	-40.79%
Premarket Change Percent	1.85
Premarket Price	$1.1
Premarket Volume	925
Price vs 200-day SMA	-77.71%
RSI	28.85
RSI Monthly	29.06
RSI Weekly	27.91
Sharpe ratio	-2.56x
Sortino ratio	-3.34
Total Return	-29.87%
Tr YTD	-80.44
Tr1m	-17.36%
Tr1w	-9.09%
Tr3m	-65.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$24
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.68
Earnings Revenue Estimate	489,472x
Earnings Revenue Estimate Growth	20.36x
Operating Income	$-21.6M
Operating margin	-874.5
Price target	$16.97
Price Target Change	$1,597
Price Target Change Top	$2,300

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,655,408%
Float Percent	79.89%
Net Borrowing	7,172,679
Shares Insiders	5.07%
Shares Institutions	17.51%
Shares Out	8,330,270
Shares Qo Q	13.78%
Shares Yo Y	29.87%
Short Float	4.84%
Short Ratio	0.89
Short Shares	3.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-22.3M
Average Volume	209,545.7x
Bv Per Share	-4.03
CAPEX	$-96,964
Ch10y	-98.46
Ch1m	-17.36
Ch1w	-9.09
Ch1y	-93.2
Ch3m	-65.28
Ch3y	-96.71
Ch5y	-98.37
Ch6m	-82.27
Change	-7.41%
Change From Open	-9.09
Close	1.08
Days Gap	1.85
Depreciation Amortization	939,136
Dollar Volume	176,835
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-21.7M
EBITDA	$-20.8M
EPS	$-4.2
F Score	2
FCF	$-20.8M
FCF EV Yield	-122.63x
FCF Per Share	$-2.49
Financing CF	21,041,954
Fiscal Year End	December
Investing CF	-96,964
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2026-04-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	3.42
Ma150ch	-70.76%
Ma20	1.25
Ma20ch	-19.87%
Net CF	502,475
Next Earnings Date	2026-08-13
Open	1.1
Optionable	Yes
Position In Range	9.09
Post Close	1
Postmarket Change Percent	4
Postmarket Price	$1.04
Ppne	4,201,191
Pre Close	1.08
Price Date	2026-07-24
Relative Volume	0.84x
Revenue	2,466,075x
SBC By Revenue	61.37x
Share Based Comp	1,513,318
Tr6m	-82.27%
Us State	Nevada
Volume	176,835
Z Score	-48.3

VolitionRx Limited (VNRX)

Coverage state: Market snapshot only — no published research

Generate the first VNRX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · VNRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VNRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VNRX

Frequently asked questions